ALEXANDRIA, Va., Dec. 23 -- United States Patent no. 12,502,136, issued on Dec. 23, was assigned to Calyan Technologies Inc. (Saint Paul, Minn.).

"Subcutaneous device for monitoring and/or providing therapies" was invented by Yatheendhar D. Manicka (Woodbury, Minn.).

According to the abstract* released by the U.S. Patent & Trademark Office: "A subcutaneously implantable device includes a housing, a first prong, and a second prong. A first electrode on the first prong is configured to contact the first lung. A second electrode on the device is configured to contact the first lung or a second lung. A third electrode on the second prong is configured to contact the heart or the tissue surrounding the heart. Sensing circuitry in the housing i...